所有心脏移植后的患者都应该服用他汀类药物来降低癌症风险吗？ - Suppr | 超能文献

Should all patients receive statins to reduce cancer risk after heart transplantation?

作者信息

Clarke Noel W, Brown Michael D

出版信息

Circulation. 2012 Jul 24;126(4):391. doi: 10.1161/CIRCULATIONAHA.112.121343. Epub 2012 Jul 3.

DOI:10.1161/CIRCULATIONAHA.112.121343

Abstract

摘要

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1

Should all patients receive statins to reduce cancer risk after heart transplantation?所有心脏移植后的患者都应该服用他汀类药物来降低癌症风险吗？

Circulation. 2012 Jul 24;126(4):391. doi: 10.1161/CIRCULATIONAHA.112.121343. Epub 2012 Jul 3.

2

Letter by Azoulay and Suissa regarding article, "statins and the risk of cancer after heart transplantation".阿祖莱和苏伊萨就“他汀类药物与心脏移植后癌症风险”一文所写的信。

Circulation. 2013 Feb 5;127(5):e439. doi: 10.1161/CIRCULATIONAHA.112.130245.

3

Letter by Schmedt and Garbe regarding article, "statins and the risk of cancer after heart transplantation".施梅特和加贝就“他汀类药物与心脏移植后癌症风险”一文所写的信。

Circulation. 2013 Feb 5;127(5):e440. doi: 10.1161/CIRCULATIONAHA.112.135707.

4

Letter by Vorlat et al regarding article, "statins and the risk of cancer after heart transplantation".沃拉特等人就“他汀类药物与心脏移植后癌症风险”一文所写的信函。

Circulation. 2013 Feb 5;127(5):e441. doi: 10.1161/CIRCULATIONAHA.112.138834.

5

Response to letters regarding article, “statins and the risk of cancer after heart transplantation”.对关于“他汀类药物与心脏移植后癌症风险”一文的信件的回复

Circulation. 2013 Feb 5;127(5):e442. doi: 10.1161/circulationaha.112.147595.

6

Statins and the risk of cancer after heart transplantation.他汀类药物与心脏移植后癌症风险。

Circulation. 2012 Jul 24;126(4):440-7. doi: 10.1161/CIRCULATIONAHA.111.081059. Epub 2012 Jul 3.

7

Pravastatin therapy is associated with reduction in coronary allograft vasculopathy in pediatric heart transplantation.普伐他汀治疗与小儿心脏移植中冠状动脉移植血管病的减少有关。

J Heart Lung Transplant. 2005 Jan;24(1):63-6. doi: 10.1016/j.healun.2003.10.013.

8

Statins in the prevention of transplant coronary artery disease: in pediatric heart recipients.

Pediatr Transplant. 2007 Aug;11(5):459-60. doi: 10.1111/j.1399-3046.2007.00710.x.

9

HMG-CoA reductase inhibitors reduce transplant coronary artery disease and mortality: evidence for antigen-independent mechanisms?HMG-CoA还原酶抑制剂可降低移植后冠状动脉疾病的发生率并降低死亡率：抗原非依赖性机制的证据？

Circulation. 1997 Sep 2;96(5):1370-3.

10

Gynaecomastia following solid organ transplantation.实体器官移植后的男性乳房发育

Transplant Proc. 2002 Sep;34(6):2227-8. doi: 10.1016/s0041-1345(02)03214-1.

引用本文的文献

1

The role of statins in patients after heart transplantation.他汀类药物在心脏移植术后患者中的作用。

Kardiochir Torakochirurgia Pol. 2015 Mar;12(1):42-7. doi: 10.5114/kitp.2015.50567. Epub 2015 Mar 31.